Fortress Diagnostics Awarded ‘Best In-Vitro Diagnostics Development & Manufacturing Company, 2021’

03 June, 2021

We are proud to announce that Fortress Diagnostics have been awarded ‘Best In-Vitro Diagnostics Development & Manufacturing Company, 2021’ by the Global Excellence Awards, hosted by Global Health & Pharma Magazine.

At Fortress Diagnostics we are dedicated to the development of high-quality, in-vitro diagnostics solutions. Each year, we reinvest turnover into Research and Development and employ a highly skilled team of research scientists to create innovative new products and optimise existing products to ensure our products are at the forefront of technology. In the last 12 months the ‘normal’ way of working has been transformed and healthcare services globally have been placed under immense pressure to administer tests and treatment for COVID-19. For Fortress, these dramatic changes meant that we had to quickly adapt to meet the growing demands of our customers that quickly required tests for COVID-19.

To date, Fortress Diagnostics have delivered over 1 million COVID-19 tests and been deemed as ‘the most suitable candidate’ for the National Coronavirus Disease 2019 Seroprevalence Programme, REACT and will continue to be used in ongoing rounds of the programme.

We would like to thank Global Health Pharma for recognising the hard work of everyone at Fortress, particularly over the last 12 months with this award and we look forward to continued growth and development.  

Contact for more information on our product ranges.

Request a Quote

Please get in touch to see how we can help

Contact Us Quote

Our website use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy & Cookies Policy